KEGG   PATHWAY: pcad05213
pcad05213                   Pathway                                

Endometrial cancer - Physeter catodon (sperm whale)
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Human Diseases; Cancer: specific types
Pathway map
pcad05213  Endometrial cancer

Physeter catodon (sperm whale) [GN:pcad]
102977431  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
102975467  EGFR; epidermal growth factor receptor isoform X3 [KO:K04361] [EC:]
102986098  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:]
102978952  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:]
102977108  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:]
102975555  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
102991779  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
102991192  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649]
102984551  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X2 [KO:K01110] [EC:]
102977392  PDPK1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:]
102995328  ILK; integrin-linked protein kinase [KO:K06272] [EC:]
102981524  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:]
102976971  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:]
102990087  RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:]
102989458  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:]
102974655  BAD; bcl2-associated agonist of cell death [KO:K02158]
102980970  FOXO3; forkhead box protein O3 isoform X2 [KO:K09408]
114483947  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
102991639  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
102981677  LOW QUALITY PROTEIN: son of sevenless homolog 2-like [KO:K03099]
102978925  SOS2; son of sevenless homolog 2 [KO:K03099]
102994715  HRAS; GTPase HRas isoform X2 [KO:K02833]
102977125  KRAS; GTPase KRas isoform X2 [KO:K07827]
102992439  LOW QUALITY PROTEIN: GTPase NRas-like [KO:K07828]
102982641  NRAS; LOW QUALITY PROTEIN: GTPase NRas [KO:K07828]
102974274  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:]
102986916  BRAF; serine/threonine-protein kinase B-raf isoform X3 [KO:K04365] [EC:]
102987866  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X2 [KO:K04366] [EC:]
102992191  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:]
102994150  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X2 [KO:K04369] [EC:]
102984305  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:]
102989074  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:]
102976778  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
102987940  MLH1; DNA mismatch repair protein Mlh1 [KO:K08734]
102988252  CDH1; cadherin-1 [KO:K05689]
102987227  CTNNB1; catenin beta-1 [KO:K02105]
102980163  CTNNA1; catenin alpha-1 [KO:K05691]
102973482  CTNNA2; catenin alpha-2 isoform X3 [KO:K05691]
102995753  CTNNA3; catenin alpha-3 isoform X3 [KO:K05691]
102986270  AXIN1; axin-1 isoform X1 [KO:K02157]
102990422  axin-2 isoform X1 [KO:K04385]
102990003  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
102973647  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
102978702  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:]
102992878  TCF7; transcription factor 7 isoform X3 [KO:K02620]
102974053  TCF7L1; transcription factor 7-like 1 [KO:K04490]
102987858  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
102996605  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
102988128  MYC; myc proto-oncogene protein [KO:K04377]
102996914  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
102985658  TP53; cellular tumor antigen p53 [KO:K04451]
102995437  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
102974987  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
102993403  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
102986518  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
102991092  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
102974256  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
102976634  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:]
102990192  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:]
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Ryan AJ, Susil B, Jobling TW, Oehler MK.
Endometrial cancer.
Cell Tissue Res 322:53-61 (2005)
Lax SF.
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
Virchows Arch 444:213-23 (2004)
Shiozawa T, Konishi I.
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
Int J Clin Oncol 11:13-21 (2006)
Hecht JL, Mutter GL.
Molecular and pathologic aspects of endometrial carcinogenesis.
J Clin Oncol 24:4783-91 (2006)
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
Molecular pathology of endometrial hyperplasia and carcinoma.
Hum Pathol 32:569-77 (2001)
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
J Clin Oncol 22:3126-32 (2004)
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
Cancer Res 55:5693-8 (1995)
Kim D, Chung J.
Akt: versatile mediator of cell survival and beyond.
J Biochem Mol Biol 35:106-15 (2002)
pcad04010  MAPK signaling pathway
pcad04012  ErbB signaling pathway
pcad04060  Cytokine-cytokine receptor interaction
pcad04110  Cell cycle
pcad04115  p53 signaling pathway
pcad04151  PI3K-Akt signaling pathway
pcad04310  Wnt signaling pathway
pcad04520  Adherens junction
KO pathway

DBGET integrated database retrieval system